Abiopharma

🔍 Adler Eric (Executive)

Company: Lexeo Therapeutics, Inc. (LXEO)

Report Date: 2025-08-18

Detailed Transactions and Holdings:

• Sold 608 shares of Common Stock at $4.668 per share (Direct)
  Date: 2025-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 67,073.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
• F2: Includes 60,546 RSUs.